Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The 'Europe Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis' report has been added to ResearchAndMarkets.com's offering.Europe Cervical Cancer Screening Market is projected to reach a value of US$ 11.45 Billion by 2028, growing at a CAGR of 4.02% during 2022-2028 European countries have adopted diverse approaches to prevent and detect cervical cancer at an early stage.

都柏林，2023年10月23日（GLOBE NEWSWIRE）--“欧洲宫颈癌筛查市场，规模，预测2023-2028，行业趋势，增长，份额，前景，通货膨胀影响，机会公司分析”报告已被添加到ResearchAndMarkets.com的提供。欧洲宫颈癌筛查市场预计到2028年将达到114.5亿美元，到2022-2028年期间增长率为4.02%。欧洲国家已采取多种方法在早期预防和检测宫颈癌。

Over half of these countries have implemented screening programs that target their entire populations. The mortality rates for cervical cancer in EU countries have been on the decline, thanks to improvements in incidence rates and survival rates. The European cervical cancer screening industry is primarily led by key market players like Abbott Laboratories, Hologic Corporation, Becton, Siemens AG, Roche Diagnostics, Quest Diagnostics, and Cardinal Health.

这些国家中有一半以上已经实施了针对全体人口的筛查计划。由于发病率和存活率的提高，欧盟国家宫颈癌的死亡率一直在下降。欧洲宫颈癌筛查行业主要由Abbott Laboratories，Hologic Corporation，Becton，Siemens AG，Roche Diagnostics，Quest Diagnostics和Cardinal Health等主要市场参与者领导。

These companies play a crucial role in shaping the industry landscape and driving advancements in cervical cancer screening technologies. With their expertise and innovative solutions, they contribute to the development of more accurate and efficient screening tests, ensuring early detection and improved patient outcomes.

这些公司在塑造行业格局和推动宫颈癌筛查技术的进步方面发挥着至关重要的作用。凭借他们的专业知识和创新的解决方案，他们有助于开发更准确和有效的筛查测试，确保早期发现和改善患者预后。

Through their research, development efforts, and strategic initiatives, these market players continue to make significant contributions to the fight against cervical cancer in Europe. Incorporating innovative features and technologies provides vendors with opportunities to attract new customers and expand their market presence in emerging economies.

通过他们的研究，开发工作和战略举措，这些市场参与者继续为欧洲抗击宫颈癌做出重大贡献。结合创新功能和技术为供应商提供了吸引新客户并扩大其在新兴经济体市场存在的机会。

This aspect is expected to be a driving force behind the growth of the cervical cancer diagnostic testing market in Europe. The increasing inci.

预计这方面将成为欧洲宫颈癌诊断测试市场增长的推动力。增加的inci。

Attachment

附件

European Cervical Cancer Screening Market

欧洲宫颈癌筛查市场